Medical and Pharmaceutical Hong Kong lung cancer survivor advocates for AI-powered screening measures Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted Rowan DunneJuly 28, 2025
Medical and Pharmaceutical U.S. tariffs on Chinese medical devices threaten global supply chains Donald Trump increased tariffs on Chinese goods several times during his presidency Joseph MortonJuly 21, 2025
Medical and Pharmaceutical Combining mammograms with lung cancer screening can boost female uptake A recent study from Stanford Medicine made this conclusion Rowan DunneJune 4, 2025
Medical and Pharmaceutical Novocure sees 6% spike from EU nod for electric lung cancer therapy gadget The Swiss company's Optune Lua device received FDA approval last fall Rowan DunneApril 22, 2025
Health and Safety FDA to reject medical device applications without cyberattack protection plans As many as 40 per cent of end-of-life devices have no protection at all against cyberattacks Joseph MortonMarch 31, 2023
Sleep ResMed Q4 earnings show considerable upside for sleep tech company In Q4, ResMed's revenue enjoyed a 4 per cent bump to $914.7 million, an 8 per cent increase over the previous year. Joseph MortonAugust 25, 2022